论文部分内容阅读
本文报道厂三唑仑在一个大学医疗中心药物利用评价(DUE)的结果.此DUE是在一个具有1100多张病床的大学综合性医疗中心的3个研究所里进行的.DUE下属委员会选定指示剂和阈值.然后经药物治疗委员会批准.本文复习了1991年1月至3月应用三唑仑的临床资料,并应用Naranjo药物不良反(ADR)概率计算法评价了ADR的发生与三唑仑应用之间的关系.共复习192名病人的临床资料,结果,138名(72%)病人使用了三唑仑,用药次数为l～46次,中位数为2次剂量;124例病人(123/192,64%)每次处方用量为0.125mg,其中年龄在70岁以上用此低剂量药(84%)较年轻病人用此低剂
This article reports the results of the Triazolam Appraisal of Drug Use (DUE) at a university medical center, which was conducted at three institutes of a university general medical center with more than 1,100 beds. The DUE subcommittee selected Indicators and thresholds.And then approved by the Medicines Council.This paper reviewed the clinical data of triazolam application from January to March 1991, and used the Naranjo ADR probability evaluation method to evaluate the relationship between the occurrence of ADR and triazole A total of 192 patients were reviewed and as a result, 138 (72%) patients were treated with triazolam in a dose of 1 to 46 times with a median of 2 doses; 124 patients (123/192, 64%) was prescribed at 0.125 mg per prescription, with this low dose (84%) aged 70 years and older using this lower dose